Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study Commentary: Role of other genes and environment should not be overlooked in monogenic disease
- 28 April 2001
- Vol. 322 (7293) , 1019-1023
- https://doi.org/10.1136/bmj.322.7293.1019
Abstract
Objective: To estimate all cause mortality from untreated familial hypercholesterolaemia free from selection for coronary artery disease. Design: Family tree mortality study. Setting: Large pedigree in Netherlands traced back to a single pair of ancestors in the 19th century. Subjects: All members of pedigree aged over 20 years with 0.5 probability of carrying a mutation for familial hypercholesterolaemia. Main outcome measure: All cause mortality. Results: A total of 70 deaths took place among 250 people analysed for 6950 person years. Mortality was not increased in carriers of the mutation during the 19th and early 20th century; it rose after 1915, reached its maximum between 1935 and 1964 (standardised mortality ratio 1.78, 95% confidence interval 1.13 to 2.76; P=0.003), and fell thereafter. Mortality differed significantly between two branches of the pedigree (relative risk 3.26, 95% confidence interval 1.74 to 6.11; P=0.001). Conclusions: Risk of death varies significantly among patients with familial hypercholesterolaemia. This large variability over time and between branches of the pedigree points to a strong interaction with environmental factors. Future research is required to identify patients with familial hypercholesterolaemia who are at extreme risk and need early and vigorous preventive measures. What is already known on this topic Familial hypercholesterolaemia is associated with excess mortality in families of patients who present with cardiovascular disease Population data are lacking What this study adds Many untreated patients with familial hypercholesterolaemia (about 40%) reach a normal life span Standardised mortality ratio was normal in the 19th century and rose to a peak in the 1930s to 1960s The variation in mortality suggests an interaction between genetic and environmental factors Objective: To estimate all cause mortality from untreated familial hypercholesterolaemia free from selection for coronary artery disease. Design: Family tree mortality study. Setting: Large pedigree in Netherlands traced back to a single pair of ancestors in the 19th century. Subjects: All members of pedigree aged over 20 years with 0.5 probability of carrying a mutation for familial hypercholesterolaemia. Main outcome measure: All cause mortality. Results: A total of 70 deaths took place among 250 people analysed for 6950 person years. Mortality was not increased in carriers of the mutation during the 19th and early 20th century; it rose after 1915, reached its maximum between 1935 and 1964 (standardised mortality ratio 1.78, 95% confidence interval 1.13 to 2.76; P=0.003), and fell thereafter. Mortality differed significantly between two branches of the pedigree (relative risk 3.26, 95% confidence interval 1.74 to 6.11; P=0.001). Conclusions: Risk of death varies significantly among patients with familial hypercholesterolaemia. This large variability over time and between branches of the pedigree points to a strong interaction with environmental factors. Future research is required to identify patients with familial hypercholesterolaemia who are at extreme risk and need early and vigorous preventive measures. What is already known on this topic Familial hypercholesterolaemia is associated with excess mortality in families of patients who present with cardiovascular disease Population data are lacking What this study adds Many untreated patients with familial hypercholesterolaemia (about 40%) reach a normal life span Standardised mortality ratio was normal in the 19th century and rose to a peak in the 1930s to 1960s The variation in mortality suggests an interaction between genetic and environmental factorsKeywords
This publication has 26 references indexed in Scilit:
- Intrafamilial variability in the clinical expression of familial hypercholesterolemia: importance of risk factor determination for genetic counsellingClinical Genetics, 2008
- Familial Hypercholesterolemia in the Finnish North KareliaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Serum cholesterol and acute myocardial infarction: a case-control study from the GISSI-2 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-Epidemiologia dei Fattori di Rischio dell'Infarto Miocardico Investigators.Heart, 1994
- Competing Mortality and Progress against CancerEpidemiology, 1994
- Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.BMJ, 1991
- Mortality in hereditary antithrombin-III deficiency—1830 to 1989The Lancet, 1991
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1990
- Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis A comparative study of genetic and environmental factors in 274 heterozygous casesAtherosclerosis, 1976
- Coronary Artery Disease in 116 Kindred with Familial Type II HyperlipoproteinemiaCirculation, 1974
- Hyperlipidemia in Coronary Heart Disease III. EVALUATION OF LIPOPROTEIN PHENOTYPES OF 156 GENETICALLY DEFINED SURVIVORS OF MYOCARDIAL INFARCTIONJournal of Clinical Investigation, 1973